The Patent Finder

Discovery Therapeutics, Inc.

Also on record
Records under this name other than patents Discovery Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Discovery Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,251,844Transdermal Therapeutic System and Method of Use Thereof for Treating Parkinsonism
Formerly held
Term ended
Ended no later than Feb 25, 2024 · Low confidence
Term endedEnded no later than Feb 25, 2024Low confidence
US 10,322,093Method for Producing a Transdermal Therapeutic System Which Contains a D2 Agonist
Formerly held
Term ended
Term ended Sep 22, 2022 · Medium confidence
Term endedTerm ended Sep 22, 2022Medium confidence
US 6,884,434Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
Formerly held
Term ended
Term ended Mar 30, 2021 · USPTO record
Term endedTerm ended Mar 30, 2021USPTO record
US 6,372,920Process for preparing nitrogen-substituted aminotetralins
Formerly held
Term ended
Term ended Nov 16, 2020 · USPTO record
Term endedTerm ended Nov 16, 2020USPTO record
US 6,271,219Topical formulations comprising skin penetration agents and the use thereof
Formerly held
Term ended
Term ended Sep 28, 2019 · USPTO record
Term endedTerm ended Sep 28, 2019USPTO record
US 7,413,747Transdermal Therapeutic System for Treating Parkinsonism
Formerly held
Term ended
Ended no later than Mar 18, 2019 · Low confidence
Term endedEnded no later than Mar 18, 2019Low confidence
US RE37,045N-6 substituted-5'-(N-substituted carboxamide)adenosines as cardiac vasodilator and antihypertensive agents
Formerly held
Term ended
Term ended Jan 21, 2019 · USPTO record
Term endedTerm ended Jan 21, 2019USPTO record
US RE36,4942-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
Formerly held
Term ended
Term ended Jan 11, 2017 · USPTO record
Term endedTerm ended Jan 11, 2017USPTO record
US 6,372,723Compositions and methods for preventing restenosis following revascularization procedures
Formerly held
Lapsed on the fee record
Ended Apr 16, 2010 · USPTO record
Lapsed on the fee recordEnded Apr 16, 2010USPTO record
US 6,339,072Compositions and methods for preventing restenosis following revascularization procedures
Formerly held
Lapsed on the fee record
Ended Jan 15, 2010 · USPTO record
Lapsed on the fee recordEnded Jan 15, 2010USPTO record
10 of 81 patents shown.
Pro members see all 81.
Pro members: see all 81 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited